Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund - Knoll Capital Management

Fred Knoll Bio, Returns, AUM, Net Worth

Fred Knoll has led Knoll Capital Management since 1987, and he personally manages Knoll Capital Fund I and Knoll Capital Fund II. Fred Knoll had previously worked with Telos Corporation, General American Investors, Murray Johnstone, and Robert Fleming. He studied at M.I.T. and got his M.B.A. from Columbia University, and his fund focuses on technology stocks.

Fred Knoll
Fund Profile
Filing Period:
Fund Name: Knoll Capital Management
Manager Fred Knoll
Portfolio Value $116,948,000
Change This QTR +1.55%
Fund Holdings Sector Distribution
Filing Period:
Last update:
No. Security Ticker Shares Value (x$1000) Activity % Port
1.
Abeona Therapeutics Inc
2,359,767 $40,234 34.4%
2.
Biohaven Pharmactl Hldg Co L
807,224 $30,150 25.78%
3.
Corbus Pharmaceuticals Hldgs
3,738,925 $26,733 22.85%
4.
Vascular Biogenics Ltd
860,605 $5,250 4.48%
5.
Anavex Life Sciences Corp
724,205 $2,998 2.56%
News, Interviews and Investor Letters